Prime Medicine Depreciation & Amortization Growth & History (PRME)

Prime Medicine's depreciation and amortization was $7.3M for fiscal 2025.

View full Prime Medicine company overview

Prime Medicine annual depreciation and amortization history

Prime Medicine annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$7.3M$1.2M+19.47%
20242024-12-31$6.1M$1.5M+31.70%
20232023-12-31$4.7M$2.4M+109.22%
20222022-12-31$2.2M$1.7M+291.55%
20212021-12-31$568,000$525,000+1220.93%
20202020-12-31$43,000

Prime Medicine depreciation and amortization trends

Over the last five fiscal years, Prime Medicine's depreciation and amortization increased from $43,000 to $7.3M, a change of $7.3M. The latest reported quarter, Q2 2026, shows $1.8M.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Prime Medicine source filings ↗

Community posts

It’s quiet here.

No posts about PRME yet. Start the conversation.

Write the first post